| [1] |
VENCLOVAS Z, ALKSNYTE A, RIMSAITE U, et al. Primary renal angiosarcoma: rare tumour with lethal outcomes[J]. Medicina (Kaunas), 2024, 60(6): 885.
|
| [2] |
HUANG S C, CHANG I Y, CHANG C J, et al. Association between hepatic angiosarcoma and end-stage renal disease: nationwide population-based evidence and enriched mutational signature of aristolochic acid exposure[J]. J Pathol, 2023, 260(2): 165-176.
|
| [3] |
田永猛, 邱卫黎. 血管肉瘤的研究现状与综合诊疗[J]. 汕头大学医学院学报, 2024, 37(4): 254-256.
|
| [4] |
薛茁蕤, 滕 菲, 胡蓉蓉, 等. 免疫检查点抑制剂导致肾脏免疫相关不良反应50例临床特征分析: 一项真实世界观察研究[J]. 中国实用内科杂志, 2025, 45(6): 522-532.
|
| [5] |
陈丹玉, 杨锦建, 罗彬杰, 等. 原发性肾血管肉瘤的临床特点及预后影响因素分析[J]. 河南外科学杂志, 2019, 25(1): 21-24.
|
| [6] |
HEO S H, SHIN S S, KANG T W, et al. Primary renal angiosarcoma with extensive hemorrhage: CT and MRI findings[J]. Int Braz J Urol, 2019, 45(2): 402-405.
|
| [7] |
OMIYALE A O, CARTON J. Clinical and pathologic features of primary angiosarcoma of the kidney[J]. Curr Urol Rep, 2018, 19(2): 4.
|
| [8] |
蔡 驰, 柯晓婷, 陈梅桂, 等. 原发性肾脏血管肉瘤的诊断及治疗研究进展[J]. 山东医药, 2020, 60(30): 104-107.
|
| [9] |
潘洁娜. CT诊断原发性肾血管肉瘤一例[J/OL]. 功能与分子医学影像学(电子版), 2017, 6(3): 1277-1278.
|
| [10] |
WAQAS M, RAHIM W, SHOHAB D, et al. Primary renal epithelioid angiosarcoma[J]. J Coll Physicians Surg Pak, 2018, 28(3): S66-S68.
|
| [11] |
孙 璐, 石宏伟, 皮国良. 血管肉瘤的分子靶向及免疫治疗研究进展[J]. 肿瘤防治研究, 2022, 49(1): 62-66.
|
| [12] |
韩冬艳, 李倩玉, 蒋虹伟, 等. 原发性肾脏血管肉瘤3例临床病理分析及文献复习[J]. 诊断学理论与实践, 2017, 16(2): 183-187.
|
| [13] |
MASTORAKI A, SCHIZAS D, GIANNAKAS T, et al. Primary angiosarcoma of the kidney: literature review of a rare nosologic entity[J]. Anticancer Res, 2020, 40(2): 625-633.
|
| [14] |
ARGANI P, SAOUD C, ANTONESCU C R. Molecular analysis of renal/adrenal angiosarcomas reveals high frequency of recurrent genetic alterations[J]. Genes Chromosomes Cancer, 2024, 63(9): e23268.
|
| [15] |
DARLINGTON D, ANITHA F S. Primary renal angiosarcoma mimicking renal cell carcinoma: a case report[J]. Cureus, 2019, 11(1): e3841.
|
| [16] |
GUAN H W, ZHANG L Z, ZHANG Q P, et al. Primary angiosarcoma arising in an angiomyolipoma of the kidney: case report and literature review[J]. Diagn Pathol, 2018, 13(1): 53.
|
| [17] |
KARAOSMANOĞLU A D, ONUR M R, SHIRKHODA A, et al. Unusual malignant solid neoplasms of the kidney: cross-sectional imaging findings[J]. Korean J Radiol, 2015, 16(4): 853-859.
|
| [18] |
孙圣坤, 徐阿祥, 张 旭. 肾脏血管平滑肌脂肪瘤的诊断及治疗进展[J]. 微创泌尿外科杂志, 2013, 2(3): 213-216.
|
| [19] |
顾基伟, 陈克敏, 刘 玉. 《请您诊断》病例42答案: 肾原发性血管肉瘤[J]. 放射学实践, 2010, 25(8): 942-943.
|
| [20] |
PEYROTTES A, BODARD S, TIMSIT M O, et al. Primary angiosarcoma of the kidney: a challenging diagnosis[J]. Fr J Urol, 2024, 34(4): 102609.
|
| [21] |
马星星, 李木子, 陈 腊, 等. STMN1在肿瘤中作用的研究进展[J]. 中南大学学报(医学版), 2025, 50(6): 1052-1059.
|
| [22] |
SHI Y K, CAI Q Q, JIANG Y, et al. Activity and safety of geptanolimab (GB226) for patients with unresectable, recurrent, or metastatic alveolar soft part sarcoma: a phase Ⅱ, single-arm study[J]. Clin Cancer Res, 2020, 26(24): 6445-6452.
|
| [23] |
YANG S, YANG J L, HAN X H, et al. Effect of JS001, a monoclonal antibody targeting programed death-1 (PD-1), on responses and disease control in patients with advanced or refractory alveolar soft part sarcoma: Results from a phase 1 trial[J]. J Clin Oncol, 2018, 36(): 11572.
|
| [24] |
李 鑫, 敖建阳, 王敬晗, 等. 胆道恶性肿瘤的免疫治疗现状及研究进展[J]. 临床肝胆病杂志, 2025, 41(12): 2447-2452.
|
| [25] |
刘 丽, 白文坤. 超声造影在乳腺癌诊断与新辅助化疗疗效评估中的研究进展[J]. 同济大学学报(医学版), 2025, 46(2): 300-304.
|
| [26] |
葛郁平, 刘 莹, 赵 林. 血管肉瘤药物治疗进展[J]. 基础医学与临床, 2024, 44(10): 1363-1367.
|